SCHEMBL7282248

SCHEMBL7282248

COc1ccc([C@H]2Cc3ccccc3N(CCN(C)C)C(=O)[C@H]2O)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1S Q13698 18/20 0.79
▸ CYP3A4 P08684 2/20 0.51
▸ TSHR P16473 2/20 0.51
▸ SLC22A1 O15245 1/20 0.51
▸ CACNA1F O60840 1/20 0.51
▸ ABCB11 O95342 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ ABCB1 P08183 1/20 0.51
▸ HRH2 P25021 1/20 0.51
▸ ADRA1A P35348 1/20 0.51
▸ SCN1A P35498 1/20 0.51
▸ SCN4A P35499 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ SCN7A Q01118 1/20 0.51
▸ CACNA1D Q01668 1/20 0.51
▸ PLAUR Q03405 1/20 0.51
▸ KCNH2 Q12809 1/20 0.51
▸ CACNA1C Q13936 1/20 0.51
▸ SCN5A Q14524 1/20 0.51
▸ SCN9A Q15858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7282237 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRSLC22A1CACNA1F
SCHEMBL7282244 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRSLC22A1CACNA1F
SCHEMBL7291898 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRSLC22A1CACNA1F
SCHEMBL7292099 1.00 CACNA1S (0.79) CACNA1SCYP3A4TSHRSLC22A1CACNA1F
SCHEMBL10609946 0.88 CACNA1S (1.00) CACNA1S
SCHEMBL10609941 0.88 CACNA1S (1.00) CACNA1S
SCHEMBL7286040 0.88 CACNA1S (0.80) CACNA1SCYP3A4TSHRSLC22A1CACNA1F
SCHEMBL7286047 0.88 CACNA1S (0.80) CACNA1SCYP3A4TSHRSLC22A1CACNA1F
SCHEMBL7282585 0.86 CACNA1S (0.76) CACNA1S
SCHEMBL7282571 0.86 CACNA1S (0.76) CACNA1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995034299-A1 INHIBITION OF INTRAOPERATIVE MIOSIS/PRODUCTION OF MYDRIASIS BY CALCIUM CHANNEL BLOCKERS TELOR OPHTHALMIC PHARMACEUTICALS, INC. (US) 1995-12-21 — — WO disclosed
US-4748239-A VASODILATORS E. R. SQUIBB & SONS, INC. (US) 1988-05-31 — — US disclosed
EP-0205334-A2 Benzazepine derivatives E.R. Squibb & Sons, Inc. (US) 1986-12-17 — — EP disclosed
Send feedback